Financial Difficulty in Patients with Blood Cancer
Leukemia
Multiple Myeloma
Plasma cell neoplasm
18 Years and older, Male and Female
LCCC2063 (primary)
NCI-2022-10367
Summary
This study measures how often financial problems happen in patients with chronic lymphocytic leukemia or multiple myeloma by collecting information about finances and quality of life.
Objectives
PRIMARY OBJECTIVE:
I. To estimate the proportion of individuals with MM and/or CLL who report experiencing financial difficulty in the past 12 months.
OUTLINE: This is an observational study.
PATIENTS: Participants complete a survey and may participate in a phone interview on study.
PHYSICIANS: Physicians complete a survey on study.
Eligibility
- Patient Eligibility Criteria: * Documentation of disease: Patients must have current diagnosis of chronic lymphocytic leukemia (CLL) and/or multiple myeloma (MM). * Patients’ medical records must be available to the registering institution. * Eligible patients must have been prescribed drug-based anticancer therapy, whether administered orally or by infusion, within the prior 12 months. Specifically, eligible patients are those who: ** Are presently being treated with infused or orally-administered anticancer therapy, OR ** Completed infused or orally-administered anti-cancer therapy in the past 12 months, OR ** Were prescribed infused or orally-administered anticancer therapy within the prior 12 months yet chose to forego treatment. * Not currently enrolled in a clinical trial in which drug is supplied by the study, or planning to enroll in a clinical trial within 12 weeks of registration. * Patients with psychiatric illness or other mental impairment that would preclude their ability to give informed consent or to respond to the telephone survey are not eligible. * Patients must be able to read and comprehend English or Spanish. * Age = 18 years Site Eligibility Criteria: * Intent to complete the Practice Survey * Access to patient medical records: Registering institution must have access to patient medical records, either on site or via request from other institutions, if recruiting patients at a site (as medical abstraction is required for collecting study data). * Sites seeking to enroll Spanish- speaking patients must have Spanish speaking staff on site or through the use of a translation service to be able to conduct the informed consent discussion in Spanish. Physician Eligibility Criteria: * The physician currently treats patients with chronic lymphocytic leukemia (CLL) and/or multiple myeloma (MM). * The physician is a treating physician at a site which has opened this protocol (LCCC 2063) and/or a site which opened the Alliance protocol (A231602CD). Eligible physicians do not need to have their own patients enrolled on this to protocol or on to A231602CD.
Treatment Sites in Georgia
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials.